Efficacy and safety of the long-acting C5 inhibitor ravulizumab in patients with atypical hemolytic uremic syndrome triggered by pregnancy: a subgroup analysis
- Gäckler, A.
- Schönermarck, U.
- Dobronravov, V.
- La Manna, G.
- Denker, A.
- Liu, P.
- Vinogradova, M.
- Yoon, S.-S.
- Praga, M.
Zeitschrift:
BMC Nephrology
ISSN: 1471-2369
Datum der Publikation: 2021
Ausgabe: 22
Nummer: 1
Art: Artikel
